| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
9,444 | 11,159 | 9,994 | 34,477 | 13,851 |
| Selling, General and Administrative Expenses
|
-32,441 | -37,914 | -46,457 | -38,461 | -38,020 |
|
Research and Development Expenses
|
-84,717 | -109,439 | -130,153 | -112,075 | -82,230 |
|
Operating Income/Expenses
|
-117,158 | -147,353 | -176,610 | -150,536 | -120,250 |
|
Total Operating Profit/Loss
|
-107,714 | -136,194 | -166,616 | -116,059 | -106,399 |
| Net Investment Income
|
-- | -- | -- | -6 | -133 |
| Irregular Income/Expenses
|
0 | -21,308 | 0 | -- | 0 |
|
Other Income/Expense, Non-Operating
|
4,697 | 8,827 | 17,502 | 14,182 | 7,181 |
|
Non-Operating Income/Expenses, Total
|
4,697 | -12,481 | 17,502 | 14,182 | 7,048 |
|
Pretax Income
|
-103,017 | -148,675 | -149,114 | -101,877 | -99,351 |
|
Provision for Income Tax
|
550 | 550 | 9 | -193 | -70 |
|
Net Income from Continuing Operations
|
-102,467 | -148,125 | -149,105 | -102,070 | -99,421 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-102,467 | -148,125 | -149,105 | -102,070 | -99,421 |
|
Net Income after Non-Controlling/Minority Interests
|
-102,467 | -148,125 | -149,105 | -102,070 | -99,421 |
|
Net Income Available to Common Stockholders
|
-102,467 | -148,125 | -149,105 | -102,070 | -99,421 |
|
Diluted Net Income Available to Common Stockholders
|
-102,467 | -148,125 | -149,105 | -102,070 | -99,421 |
| Basic EPS
|
-1.03 | -1.59 | -1.65 | -1.38 | -1.64 |
| Diluted EPS
|
-1.03 | -1.59 | -1.65 | -1.38 | -1.64 |
|
Basic Weighted Average Shares Outstanding
|
99,765.1640 | 93,389.2830 | 90,317.9250 | 73,807.5970 | 60,801.1330 |
|
Diluted Weighted Average Shares Outstanding
|
99,765.1640 | 93,389.2830 | 90,317.9250 | 73,807.5970 | 60,801.1330 |
|
Reported Normalized Basic EPS
|
-1.36 | -1.36 | -- | -- | -- |
|
Reported Normalized Diluted EPS
|
-1.36 | -1.36 | -- | -- | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-103,017 | -148,675 | -149,114 | -101,877 | -99,351 |
|
EBITDA
|
-100,471 | -145,030 | -145,187 | -98,352 | -97,729 |
|
Normalized EBITDA
|
-90,875 | -110,968 | -128,379 | -84,630 | -85,880 |
|
Normalized Income
|
-92,871 | -126,817 | -132,298.0085 | -91,884.1594 | -90,630.2269 |
|
Total Unusual Items
|
9,596 | 34,062 | 16,808 | 13,722 | 11,849 |
|
Total Unusual Items Excluding Goodwill
|
9,596 | 34,062 | 16,808 | 13,722 | 11,849 |
|
Tax Effect of Unusual Items
|
0 | 136.2480 | 1.0085 | 3,536.1594 | 3,058.2269 |
12/31/2022 - 7/23/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade